Bad weather leads to a shorter planting season.
Analyst Roni Biron has downgraded Israel Chemicals to "Neutral" following K+S's profit warning and potash price cut.
However, there was a strong rise in the exports of pharmaceuticals.
BDO Ziv Haft surveyed 170 large and mid-sized firms.
Gadot Biochemicals jumped 35%, above the offer price.
Shipping subsidiary Zim revenue fell to $622 million, from $1.04 billion in the corresponding quarter.
Erez Vigodman will replace Avraham Bigger, who will stay on as chairman.
Revenue was 41% less than the corresponding quarter of 2008.
The company is considering two alternatives for the plant.
The permit paves the way for the merger of the companies.
Antitrust Authority director general Ronit Kan has begun a probe.
CEO Nadav Shachar: Israel Chemicals not only has a monopoly on the country's natural resources, it got an additional gift when potash prices controls were lifted.
Dead Sea Works: Haifa Chemicals wants an extraordinary massive discount.
OpTier's solution will enable the tax authority to monitor all activities made by taxpayers on its website.
Manufacturers: Industrial output fell 5.5% between September 2008 and January 2009.
The company has NIS 1.58 billion in debt that is due to mature in 2009.
The company's profits eligible for distribution total $1.9 billion.
UBS reiterates its "Buy" recommendation for Israel Chemicals with a target price of NIS 43.
There was demand for the bond issue from more than 100 Israeli and foreign institutional investors.
"Business customers are almost unable to receive new credit lines from the Israeli banking system even when we are talking about financing a good deal."